24
Participants
Start Date
September 1, 2016
Primary Completion Date
April 11, 2023
Study Completion Date
April 11, 2023
Cisplatin
Given intraperitoneally
Hyperthermic Intraperitoneal Chemotherapy
Undergo HIPEC
Mitomycin
Given intraperitoneally
M D Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER